WuXi Biologics Achieves CDP Highest “A” Ratings in Both Climate Change and Water Security
SHANGHAI, Dec. 19, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK) announced that it has been named to the CDP "A" lists for both Climate Change and Water Security for 2025, underscoring its leadership in environmental stewardship and transparent disclosure. Climate Change Leadership Being recognized with an "A" rating by CDP for Climate Change affirms WuXi Biologics' leadership in environmental performance....
Prepare for a Healthier Holiday Season with Wellness Tips from VARON Oxygen Concentrators
MANILA, Philippines , Dec. 19, 2025 /PRNewswire/ -- As the holiday season begins to unfold in the Philippines, families are starting to plan gatherings, reunions, and early celebrations. For households with elderly relatives or loved ones managing respiratory conditions such as COPD, asthma or other breathing difficulties, this period of increased activity can bring...
SG-based Startup Galatek Raises $30M Series A to Accelerate AI-powered Automation in Life Sciences and Semiconductor Manufacturing
SINGAPORE, Dec. 19, 2025 /PRNewswire/ -- Galatek, a fast-growing Singapore-based automation and artificial intelligence (AI) startup, announced today that it has secured approximately US$30 million in Series A funding. The funding will accelerate the company's development of innovative products in life sciences and advanced semiconductor manufacturing, strengthen its global supply chain, and deepen local expertise in key markets across Europe, North...
NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
NANJING, China and GAITHERSBURG, Md., Dec. 19, 2025 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced that the new drug application for Tinengotinib tablets has been accepted by the Center for Drug Evaluation ("CDE")of the National Medical Products Administration ("NMPA") of the PRC. It is intended for the treatment of adults with unresectable advanced or metastatic cholangiocarcinoma (CCA) who have...
NGT Launches Wellness Campaign with JOGUMAN…Unveils Four Special-Edition Products
SEOUL, South Korea, Dec. 19, 2025 /PRNewswire/ -- Natural Good Things (NGT), a women's inner-care brand, has partnered with JOGUMAN—an IP managed globally by IPX (formerly LINE FRIENDS)—to launch its new wellness campaign, "Small but Healthy." Through the meeting, NGT has introduced four special-edition products. NGT is a wellness brand equipped with its own R&D capabilities and ingredient manufacturing...
MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan
- South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM® targeting the Japanese knee osteoarthritis market. SEOUL, South Korea, Dec. 19, 2025 /PRNewswire/ -- MEDIPOST Co., Ltd. (KOSDAQ 078160), a fully integrated cell therapy biotechnology company, today announced a multi-year partnership with Japan's Teikoku Seiyaku Co., Ltd. for...
Corti Unlocks “Surgical” AI Improvement, Outperforming Big Tech in Interpretability Benchmark
New "GIM" method tops MIB global leaderboard, offering the industry a scalable way to inspect and improve billion-parameter models. COPENHAGEN, Denmark and NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Corti, a healthcare AI infrastructure company, today announced a major advance in AI transparency, achieving the #1 position on the Hugging Face Mechanistic Interpretability Benchmark (MIB). The benchmark, maintained by...
Neuraxpharm Goes Live with TraceLink MINT to Standardize Real‑Time Data Exchange Across Its Global Supply Chain Network
The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestration BOSTON, Dec. 18, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced that Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of central...
Freda Key C Presents Advanced Recombinant Collagen Delivery Technology at SCC79
Novel Delivery System for High-Molecular-Weight Collagen Advances Anti-Aging Science at the Society of Cosmetic Chemists' Annual Meeting NEW YORK, Dec. 18, 2025 /PRNewswire/ -- Shandong Freda Biotech Co., Ltd. and its medical-aesthetic skincare brand Key C announced the presentation of a novel collagen delivery technology at the Society of Cosmetic Chemists' 79th Annual Scientific Meeting (SCC79), unveiling a new skin delivery approach...
Global study targets dengue as disease threatens nearly half the world’s population
LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models have been published, but few have been tested in real public-health settings. Now, researchers from the US and Australia are launching a field evaluation in Vietnam to see whether a new early-warning platform can support earlier interventions against a disease...
